GGrantIndex
Sort

50,496 grants matching lung cancer

RRM1 in the Management of Lung Cancer

$571,979
Gerold Bepler · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA

Identifying Therapeutic Targets for Stage III Melanoma

$571,965
Anand K Ganesan · University Of California-Irvine · R01 · FY2022 · CA

Transgenic Models for Breast Cancer

$571,893
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Chemoprevention of Tobacco Related Cancer in Animals

$571,810
University Of Toledo Health Sci Campus · R01 · FY2002 · CA

Epigenetic Drivers of Cancer (PQ 10)

$571,757
Peter W Laird · University Of Southern California · R01 · FY2014 · CA

DAP12 and the host response to cryptococcosis

$571,755
Lena J Heung · Cedars-Sinai Medical Center · R01 · FY2022 · AI

A transformative drug discovery platform for allosteric kinase inhibitors

$571,741
Nicholas Mark Levinson · University Of Minnesota · R01 · FY2023 · CA

A transformative drug discovery platform for allosteric kinase inhibitors

$571,741
Nicholas Mark Levinson · University Of Minnesota · R01 · FY2022 · CA

Engineering immunotherapeutic probiotics to mitigate irAE

$571,668
Tal Danino · Columbia Univ New York Morningside · U01 · FY2024 · CA

(PQB4) Age-cancer interplay of genome and epi-genome in human lung

$571,652
Jan No Middle Name Vijg · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · CA

Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease

$571,606
Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Developmental pathways regulating adult lung quiescence

$571,587
Edward E Morrisey · University Of Pennsylvania · R01 · FY2017 · HL

Tissue Resident memory T cell responses to cancer

$571,578
Mary J Turk · Dartmouth College · R01 · FY2025 · CA

TARGETING A NOVEL CELL SURFACE SERINE PROTEASE FOR LUNG CANCER THERAPY

$571,551
The University Of Texas Southwestern Medical Center · · FY2020 · Defense Health Agency

Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy

$571,456
Jun Wang · New York University School Of Medicine · R37 · FY2025 · CA

CAREER: Investigating the Cellular Electrome as a Biomarker in Red Blood Cell Physiology and Pathology

$571,441
Erin A Henslee · Wake Forest University · · FY2022 · ENG

Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma

$571,434
David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2015 · CA

Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations

$571,427
Muhammad Hamid Zaman · Boston University (Charles River Campus) · U01 · FY2017 · CA

Research Program

$571,362
Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2024 · CA

Role of IRF2 in cancer immune evasion and immunotherapy

$571,214
Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA

Role of IRF2 in cancer immune evasion and immunotherapy

$571,214
Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer

$571,207
Joseph Giles Winger · Duke University · R01 · FY2025 · CA

Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer

$571,142
Punita Dhawan · University Of Nebraska Medical Center · R01 · FY2021 · CA

I-SCREEN: Increasing Screening for Cancer using a Randomized Evaluation of EHR-based Nudges

$571,115
Amol S Navathe · University Of Pennsylvania · R33 · FY2022 · AG

Small molecule probes of MYC stability and function intumorigenesis

$570,930
Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2025 · CA